Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-12

Clinical Trial Update: An Open Label Study in Healthy Volunteers to Compare Chronocort® to Hydrocortisone [Phase 1]

View source ↗

Summary

Open-label Phase 1 study in healthy volunteers comparing Chronocort (modified-release hydrocortisone) to hydrocortisone.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chronocort
  • HYDROCORTISONE (HYDROCORTISONE)

Snippet

Sponsor: Neurocrine UK Limited | Conditions: Congenital Adrenal Hyperplasia, Adrenal Insufficiency | Phase 1 | Status: COMPLETED